Nepafenac

Product Name: Nepafenac
CAS No.: 78281-72-8
Chemical Name: Nepafenac
Synonyms: Nevanac;CS-328;AL 6515;AHR 9434;Nepafenac;Nepafanac;Nepafenac>Nepafenac API;NEPAFENAC STD;Nepafenac - WS
CBNumber: CB01116872
Molecular Formula: C15H14N2O2
Formula Weight: 254.28
MOL File: 78281-72-8.mol

More

Less

Nepafenac Property

Melting point:: 177-181°C
Boiling point:: 562.5±50.0 °C(Predicted)
Density: 1.249±0.06 g/cm3(Predicted)
storage temp.: room temp
solubility: DMSO: ≥5mg/mL
form: powder
pka: 16.09±0.40(Predicted)
color: faint yellow to dark yellow
Water Solubility: 0.014 mg/mL in water
Merck: 14,6469
InChI: InChI=1S/C15H14N2O2/c16-13(18)9-11-7-4-8-12(14(11)17)15(19)10-5-2-1-3-6-10/h1-8H,9,17H2,(H2,16,18)
InChIKey: QEFAQIPZVLVERP-UHFFFAOYSA-N
SMILES: C1(CC(N)=O)=CC=CC(C(=O)C2=CC=CC=C2)=C1N
CAS DataBase Reference: 78281-72-8(CAS DataBase Reference)

More

Less

Safety

Hazard Codes: N
Risk Statements: 50/53
Safety Statements: 60-61
RIDADR: UN 3077 9 / PGIII
WGK Germany: 3
RTECS: CY1480710
HS Code: 2924.29.6250

More

Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)

Signal word

Warning

Hazard statements

H400Very toxic to aquatic life

Precautionary statements

P273Avoid release to the environment.

P391Collect spillage. Hazardous to the aquatic environment

P501Dispose of contents/container to..…

More

Less

N-Bromosuccinimide Price

Sigma-Aldrich

Product number: SML0288
Product name: Nepafenac
Purity: ≥98% (HPLC)
Packaging: 10mg
Price: $81.4
Updated: 2024/03/01

Sigma-Aldrich

Product number: SML0288
Product name: Nepafenac
Purity: ≥98% (HPLC)
Packaging: 50mg
Price: $316
Updated: 2024/03/01

TCI Chemical

Product number: N0932
Product name: Nepafenac
Purity: >98.0%(HPLC)(T)
Packaging: 200mg
Price: $168
Updated: 2024/03/01

TCI Chemical

Product number: N0932
Product name: Nepafenac
Purity: >98.0%(HPLC)(T)
Packaging: 1g
Price: $589
Updated: 2024/03/01

Cayman Chemical

Product number: 23700
Product name: Nepafenac
Purity: ≥98%
Packaging: 10mg
Price: $44
Updated: 2024/03/01

More

Less

Nepafenac Chemical Properties,Usage,Production

Description

Nepafenac, launched by Alcon Laboratories, is a topical ophthalmic medication indicated for the treatment of ocular pain and inflammation associated with cataract surgery. Nepafenac is a prodrug of amfenac, which is an NSAID and a potent non-selective inhibitor of COX-1 (IC50=0.25 μM)) and COX-2 (IC50=0.15μM). Nepefenac itself exhibits only weak activity against COX-1 (IC50=64.3μM). Amfenac (Fenazox) has been marketed in Japan since 1986 for the treatment of rheumatoid arthritis, post-surgical pain, and inflammation. With most NSAIDs that are currently being used as topical ophthalmic agents, the maximum drug concentration is achieved on the ocular surface, with progressively lower concentrations in the cornea, aqueous humor, vitreous, and retina. Nepafenac has been found to have a penetration coefficient that is 4-28 times greater than that achieved with conventional NSAIDs such as diclofenac, bromofenac, and ketorolac. In addition, the bioconversion of nepefenac to amfenac is primarily mediated by ocular tissue hydrolases, specifically in the iris, ciliary body, retina, and choroid. The enhanced permeability of nepefenac combined with rapid bioactivation in the ocular tissue translates into superior anti-inflammatory efficacy at the target sites.

Chemical Properties

Nepafenac is a light Yellow Solid or powder. It is soluble in organic solvents such as ethanol, DMSO, and dimethyl formamide (DMF).

Originator

AH Robins (US)

Uses

Nepafenac is a non-steroidal anti-inflammatory drug (NSAID), usually sold as a prescription eye drop. It reduces pain and inflammation in the eyes. Nepafenac ophthalmic is used to reduce pain and swelling after cataract surgery.

Definition

ChEBI: Nepafenac is a monocarboxylic acid amide that is amfenac in which the carboxylic acid group has been converted into the corresponding carboxamide. It is a prodrug for amfenac, used in eye drops to treat pain and inflammation following cataract surgery. It has a role as a prodrug, a cyclooxygenase 2 inhibitor, a cyclooxygenase 1 inhibitor, a non-steroidal anti-inflammatory drug and a non-narcotic analgesic.

brand name

Nevanac (Alcon).

Biochem/physiol Actions

Nepafenac is a NSAID (nonsteroidal anti inflammatory drug) that is routinely used in opthamology to control pain following cataract surgery.

Clinical Use

Nepafenac is a novel ophthalmic non-steroidal anti-inflammatory drug (NSAID), for the treatment of eye pain and inflammation caused by cataract surgery, compared with traditional NSAIDs, chemical structure of Nepafenac is conducive to make it rapidly penetrate the cornea and distribute to its target site, which is helpful to reduce the accumulation of the drug in the corneal surface and to reduce the incidence of complications of the eye surface, it has many advantages such as infiltration, targeting strong, little toxic side effects and so on.
August 19, 2005 ,the US Food and Drug Administration (FDA) approved nepafenac ophthalmic suspension for the treatment of cataract surgery-related pain and inflammation, it is the first ophthalmic NSAID prodrug formulation approved for marketing.
Nepafenac after ocular administration, can rapidly pass through the cornea , and under the action of eye tissue hydrolytic enzymes,it can become into ammonia diclofenac (a kind of NSAID); and ammonia diclofenac by inhibiting prostaglandin H synthase ( cyclooxygenase), can block prostaglandin synthesis to play its role as an anti-inflammatory analgesic. As is known, prostaglandin is one of the media causing ocular inflammation it can lead to blood-aqueous barrier crash, vasodilatation, increased vascular permeability and leukocyte chemotaxis, etc. In addition, prostaglandins can also control contraction of the iris sphincter through non-cholinergic mechanism which can trigger the miosis reaction during eye surgery and after surgery. After ocular administration of NSAIDs, it can inhibit prostaglandins synthesis in the iris, ciliary body and conjunctiva, so people can prevent eye inflammation, and reduce the associated pain.
The above information is edited by the chemicalbook of Tian Ye.

Synthesis

The synthesis of nepafenac started with commercially available 2-amino-benzophenone (89). Compound 89 was reacted with t-butyl hypochrite at ¨C 65??C in DCM to give a mono-N-chloroaniline (90) which was subsequently treated with methylthioacetamide in THF at ¨C65??C in the same pot to give an aza-sulfonium salt 91 as a solid. Compound 91 was slurred in DCM and triethylamine was added to give sulfer ylide 92 intermediate which under-went a Sommelet-Hauser type rearrangement to give compound 93 after re-aromatization of the intermediate cyclohexadienone imine. Compound 93 was finally reduced with Raney nickel to give nepafenac (XIV) in 73% yield as yellow needles.

Veterinary Drugs and Treatments

Nepafenac is a nonsteroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac is thought to inhibit the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production. Nepafenac is indicated for the treatment of pain and inflammation associated with cataract surgery.

Clinical claims and research

In preclinical models, a single topical ocular dose of nepefenac (0.1%) inhibits prostaglandin synthesis in the iris/ciliary body by 85–95% for more than 6 h, and in the retina/choroid by 55% for up to at least 4 h. By comparison, diclofenac (0.1%) shows 100% inhibition of prostaglandin synthesis in the iris/ciliary body for only 20 min, with 75% recovery observed within 6 h. Diclofenac’s inhibition of prostaglandin synthesis in the retina/choroids is minimal. The recommended dose of nepafenac ophthalmic suspension is one drop in the affected eye(s) three times daily beginning one day prior to cataract surgery, continued on the day of surgery and through the first two weeks of the postoperative period. Although the drug is applied topically, low but quantifiable plasma concentrations of nepefenac and amfenac are observed in majority of the subjects following t.i.d. dosing of nepefenac ophthalmic solution. The clinical significance of the systemic absorption of nepefenac after ophthalmic administration is unknown. The efficacy of nepafenac was demonstrated in two placebo-controlled clinical studies involving over 680 patients. Nepafenac suspension was dosed three times daily, beginning one day prior to cataract surgery, continuing on the day of surgery, and for 14 days postoperatively.

Mode of action

Nepafenac is a non-steroidal anti-inflammatory and analgesic prodrug. After topical ocular dosing, nepafenac penetrates the cornea and is converted by ocular tissue hydrolases to amfenac, a nonsteroidal anti-inflammatory drug. Amfenac inhibits the action of prostaglandin H synthase (cyclooxygenase), an enzyme required for prostaglandin production.

References

[1] bucolo c1, marrazzo g, platania cb, romano gl, drago f, salomone s. effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation. j pharm pharmacol. 2014 jul;66(7):954-60.
[2] marshall jc1, caissie al, cruess sr, cools-lartigue j, burnier mn jr. the effects of a cyclooxygenase-2 (cox-2) expression and inhibition on human uveal melanoma cell proliferation and macrophage nitric oxide production. j carcinog. 2007 nov 27;6:17.

Nepafenac Preparation Products And Raw materials

Raw materials

Preparation Products

More

Less

Nepafenac Suppliers

Americas 1 Brazil 1 Canada 1 China 262 China Hong Kong 1 Czech Republic 1 Europe 1 France 1 India 52 Italy 2 Japan 1 Poland 1 Spain 1 United Kingdom 3 United States 39 Global 368

LGM Pharma

Tel: 1-(800)-881-8210
Fax: 615-250-9817
Email: inquiries@lgmpharma.com
Country: United States
ProdList: 2123
Advantage: 70

MedChemexpress LLC

Tel: 021-58955995
Fax: 609-228-5909
Email: sales@medchemexpress.cn
Country: United States
ProdList: 4861
Advantage: 58

AdooQ BioScience, LLC

Tel: +1 (866) 930-6790
Fax: +1 (866) 333-9607
Email: info@adooq.com
Country: United States
ProdList: 2782
Advantage: 58

TargetMol Chemicals Inc.

Tel: +1-781-999-5354 +1-00000000000
Email: marketing@targetmol.com
Country: United States
ProdList: 32161
Advantage: 58

InvivoChem

Tel: +1-708-310-1919 +1-13798911105
Fax: 708-557-7486
Email: sales@invivochem.cn
Country: United States
ProdList: 6391
Advantage: 58

Cckinase, Inc.

Tel: +1 (732)236-3202
Email: sales@cckinase.com
Country: United States
ProdList: 2738
Advantage: 58

BOC Sciences

Tel: +1-631-485-4226
Fax: 1-631-614-7828
Email: inquiry@bocsci.com
Country: United States
ProdList: 19553
Advantage: 58

Cato Research Chemicals Inc.

Tel: 020-81215950 4000-868-328
Email: customer@uwalab.com
Country: United States
ProdList: 10404
Advantage: 58

Protheragen-ING

Tel: +16313385890
Email: info@protheragen-ing.com
Country: United States
ProdList: 3868
Advantage: 58

TargetMol Chemicals Inc.

Tel
Email: support@targetmol.com
Country: United States
ProdList: 38631
Advantage: 58

Aladdin Scientific

Tel: +1-+1(833)-552-7181
Email: sales@aladdinsci.com
Country: United States
ProdList: 57505
Advantage: 58

ApexBio Technology

Tel: --
Fax: --
Email: sales@apexbt.com
Country: United States
ProdList: 6251
Advantage: 58

SynFine Research

Tel: --
Fax: --
Email: research@synfine.com
Country: United States
ProdList: 1024
Advantage: 68

Acanthus Research

Tel: --
Fax: --
Email: inquiries@acanthusresearch.com
Country: United States
ProdList: 46
Advantage: 50

Selleck Chemicals LLC

Tel: --
Fax: --
Email: info@selleckchem.com
Country: United States
ProdList: 824
Advantage: 60

Cayman Chemical Company

Tel: --
Fax: --
Email: cayman@caymanchem.com
Country: United States
ProdList: 6213
Advantage: 81

CQ INTERNATIONAL CO INC

Tel: --
Fax: --
Email: info@cqici.com
Country: United States
ProdList: 76
Advantage: 58

Interchem Corporation USA

Tel: --
Fax: --
Email: esa@interchem.com
Country: United States
ProdList: 469
Advantage: 58

Chemwerth, Inc.

Tel: --
Fax: --
Email: sales@chemwerth.com
Country: United States
ProdList: 14
Advantage: 58

Selleck Chemicals LLC

Tel: --
Fax: --
Email: sales@selleckchem.com
Country: United States
ProdList: 1848
Advantage: 58

Byron Chemical Company, Inc

Tel: --
Fax: --
Email: bcc@byronchemical.com
Country: United States
ProdList: 88
Advantage: 58

Albany Molecular Research Inc. (AMRI)

Tel: --
Fax: --
Email: Customerservice@amriglobal.com
Country: United States
ProdList: 61
Advantage: 58

TOPCHEM PHARMACEUTICALS LTD

Tel: --
Fax: --
Email: Vinchem@vinchem.com
Country: United States
ProdList: 140
Advantage: 58

Kare Bay Biochem Inc.

Tel: --
Fax: --
Email: product@karebaybio.com
Country: United States
ProdList: 110
Advantage: 58

European Technologies Incorporated

Tel: --
Fax: --
Email: info@etichem.com
Country: United States
ProdList: 12
Advantage: 58

OChem Incorporation

Tel: --
Fax: --
Email: sales@ocheminc.com
Country: United States
ProdList: 6501
Advantage: 60

Genegobio Inc.

Tel: --
Fax: --
Email: mark@genegobio.com
Country: United States
ProdList: 195
Advantage: 0

ACIC Fine Chemicals Inc.

Tel: --
Fax: --
Email: sales@acic.com
Country: United States
ProdList: 492
Advantage: 48

United States Biological

Tel: --
Fax: --
Email: chemicals@usbio.net
Country: United States
ProdList: 6214
Advantage: 80

MedChemExpress

Tel: --
Fax: --
Email: sales@medchemexpress.com
Country: United States
ProdList: 6398
Advantage: 58

CEDARBURG PHARMACEUTICALS INC

Tel: --
Fax: --
Email: CorporateCommunications@amriglobal.com
Country: United States
ProdList: 34
Advantage: 58

MYLAN LABORATORIES LTD

Tel: --
Fax: --
Email: info@amstock.com
Country: United States
ProdList: 179
Advantage: 58

Combi-Blocks Inc.

Tel: --
Fax: --
Email: sales@combi-blocks.com
Country: United States
ProdList: 6618
Advantage: 69

Riedel-de Haen AG

Tel: --
Fax: --
Country: United States
ProdList: 6773
Advantage: 87

TCI America

Tel: --
Fax: --
Email: sales@tciamerica.com
Country: United States
ProdList: 6909
Advantage: 75

Matrix Scientific

Tel: --
Fax: --
Email: sales@matrixscientific.com
Country: United States
ProdList: 6632
Advantage: 80

Santa Cruz Biotechnology, Inc.

Tel: --
Fax: --
Email: scbt@scbt.com
Country: United States
ProdList: 3597
Advantage: 60

2A PharmaChem USA

Tel: --
Fax: --
Email: sales@2apharmachem.com
Country: United States
ProdList: 6137
Advantage: 39

3B Scientific Corporation

Tel: --
Fax: --
Email: sales@3bsc.com
Country: United States
ProdList: 6718
Advantage: 47

More

Less

View Lastest Price from Nepafenac manufacturers

Baoji Guokang Bio-Technology Co., Ltd.

Product: Nepafenac 78281-72-8
Price: US $4126.00/g/Bag
Min. Order: 500g
Purity: 99%
Supply Ability: 100kg
Release date: 2021-06-03

Sinoway Industrial co., ltd.

Product: Nepafenac 78281-72-8
Price: US $0.00/Kg/Bag
Min. Order: 2Kg/Bag
Purity: 98.5% up / EP
Supply Ability: 20 tons
Release date: 2022-12-02

Hebei Zhuanglai Chemical Trading Co Ltd

Product: Nepafenac 78281-72-8
Price: US $50.00/kg
Min. Order: 1kg
Purity: 99
Supply Ability: 5000
Release date: 2024-12-10

78281-72-8, NepafenacRelated Search:

4-Aminobenzoic acid Glycinamide N-Acetylsulfanilyl chloride Glycine 2-Phenylacetamide Betaine Acetamide ALTRENOGEST Pranoprofen Tacrolimus Tafluprost Urea Pidotimod 2-Amino-3-benzoyl-alpha-(methylthio)benzeneacetamide 2-AMino-3-benzoyl-5-chlorobenzeneacetaMide 7-BENZOYL-1,3-DIHYDRO-INDOL-2-ONE Nepafenac Impurity 173262-94-7

AHR 9434

AL 6515

Nevanac

Nepafenac

2-(2-amino-3-benzoyl-phenyl)acetamide

2-Amino-3-benzoylbenzeneacetamide

Nepafenac - WS

nepafenac,Nevance

Nepafanac

(R)-(but-3-yn-2-yloxy)trimethylsilane

Nepafenac, 99%, a selective COX-2 inhibitor

CS-328

Nepafenac&gt

Benzeneacetamide, 2-amino-3-benzoyl-

Nepafenac USP/EP/BP

Nepafenac API

Nepafenac (AHR9434

NepafenacQ: What is Nepafenac Q: What is the CAS Number of Nepafenac Q: What is the storage condition of Nepafenac Q: What are the applications of Nepafenac

Nepafenac/AHR9434/AL6515/Nevanac

NEPAFENAC STD

Nepafenac (200 mg)

78281-72-8

8281-72-8

C15H9D5N2O2

Nevanac

Other APIs

Amines

Aromatics

Intermediates & Fine Chemicals

Isotope Labelled Compounds

Pharmaceutical intermediate

Pharmaceuticals

API